STAT+: ‘Aduhelm left room’: Lilly CEO eyes competition with Biogen Alzheimer’s drug
Though a rival’s Alzheimer’s drug reached the market first, the CEO of Eli Lilly spoke…
Though a rival’s Alzheimer’s drug reached the market first, the CEO of Eli Lilly spoke…